ID

23891

Descripción

Study part: Adverse Events- Post- Vaccination Observation Booster Dose. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Palabras clave

Versiones (1)
  1. 16/7/17 16/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

16 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adverse Events- Post- Vaccination Observation Booster Dose Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Inglés

Adverse Events- Post- Vaccination Observation Booster Dose

1 formularios  
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
Descripción

ADVERSE EVENTS – POST–VACCINATION OBSERVATION

Alias
UMLS CUI-1
C0877248
Subject number
Descripción

Subject number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
Descripción

Adverse Events

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Volver a la parte superior de la página

Similar models

Adverse Events- Post- Vaccination Observation Booster Dose

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
C0877248 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
text
C0877248 (UMLS CUI [1])
Adverse Events
Code List
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
CL Item
Information not retrievable [U (Information not retrievable [U)
CL Item
No Vaccine administered [NA (No Vaccine administered [NA)
CL Item
No [N (No [N)
CL Item
Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y (Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial